Blood-derived anti-inflammatory protein solution blocks the effect of IL-1# on human macrophages in vitro

Author: O'Shaughnessey
Year: 2011


Objective: The purpose of this research  was to determine if an autologous protein solution (APS), prepared from platelet-rich plasma (PRP), could reduce the deleterious effects of inflammatory cytokines in vitro.

Methods: APS was prepared by processing human blood in a tuned density buoy separation device (Platelet Separation System, Biomet Biologics, LLC) to produce platelet-rich plasma (PRP) and processing the PRP in a concentration device containing polyacrylimide beads to produce a highly concentrated anti-inflammatory solution. A functional assay was designed using recombinant interleukin (IL)-1b to upregulate IL-8 production by human mono-cytes. Either recombinant human interleukin-1 receptor antagonist (rhIL-1ra) or APS was added to some samples to determine if a reduced inflammatory response could be identified in vitro. The enzyme-linked immuno-sorbent assay (ELISA) method was employed to perform cytokine analyses, and Student’s t test (a = 0.05) was used for all statistical analyses.

Results: Both the rhIL-1ra and the APS reduced the effect of IL-1b on human macrophages in vitro. This was mea- sured by the reduced production of IL-8 and tumor necrosis

Get in touch

Find your clinic

We offer appointments nationwide and now working with partners abroad providing cutting edge Regenerative Medicine to patients in UK, Italy, Australia, Spain and Pakistan.